22 Jul 2022
New research, published in Diabetes, indicates that sRAGE may prevent type 1 diabetes by correcting faulty regulatory T-cells to counter the autoimmune response and may also be useful in treating existing type 1 diabetes.
News Medical
Migraines and menopause symptoms linked to cardiovascular disease risk
19 Apr 2024
Risk of postpartum depression associated with stress during adolescence
19 Apr 2024
Surgery for hypoparathyroidism sees reduced facture rates
19 Apr 2024
Patients with type 2 diabetes taking antidepressants have a higher mortality risk
19 Apr 2024
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024